Notice of Registration - 2012
[Federal Register Volume 77, Number 54 (Tuesday, March 20, 2012)]
[Notices]
[Page 16264]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6698]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration;
Noramco Inc. (GA)
By Notice dated November 21, 2011, and published in the Federal
Register on November 29, 2011, 76 FR 73679, Noramco Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
| Drug |
Schedule |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Morphine-N-oxide (9307) |
I |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Hydrocodone (9193) |
II |
| Morphine (9300) |
II |
| Oripavine (9330) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Carfentanil (9743) |
II |
| Tapentadol (9780) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Noramco Inc., to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Noramco Inc., to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: March 8, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-6698 Filed 3-19-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
